Class action litigation brought by institutional shareholders is on the rise. According to this panel, the litigation against corporations (and often individual board members) is less frequent since institutional shareholders have come to the forefront of these cases. However, they are also more severe than in the past, and more credible. The litigation is usually preceded by lengthy investigation and analysis. Moreover, the remedy sought by institutional shareholders is by no means limited to monetary damages; significantly, the cases seek reform of corporate governance as well.
Related Insights
12 November 2024
Events
MEMA Original Equipment Suppliers Annual Conference 2024
Join Foley at the MEMA Original Equipment Suppliers Annual Conference on November 12-13.
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.
05 November 2024
Health Care Law Today
New HCPCS for Advanced Primary Care Management
The Center for Medicare & Medicaid Services issued the display copy of the final Calendar Year 2025 Physician Fee Schedule on November 1, 2024, which included three new Healthcare Common Procedure Coding System codes for advanced primary care management.